Company · CIK 1481512
Ra Pharmaceuticals, Inc.
| CIK | 1481512 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2016-11-29 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-221266 | 2017-11-01 | 2020-04-08 | 8 | |
| 333-231320 | 2019-05-09 | 2019-07-24 | 4 | |
| 333-213917 | 2016-09-30 | 2016-10-26 | 5 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2020-04-08 | EFFECTDeclared effective | 333-221266 | 9999999995-20-000702 |
| 2019-07-24 | 424B5Shelf takedown | 333-231320 | 0001047469-19-004362 |
| 2019-07-23 | 424B5Shelf takedown | 333-231320 | 0001047469-19-004330 |
| 2019-05-09 | 424B5Shelf takedown | 333-231320 | 0001047469-19-002989 |
| 2019-05-09 | S-3ASRShelf registered | 333-231320 | 0001047469-19-002981 |
| 2018-12-12 | 424B5Shelf takedown | 333-221266 | 0001047469-18-007619 |
| 2018-12-11 | 424B5Shelf takedown | 333-221266 | 0001047469-18-007560 |
| 2018-05-09 | 424B5Shelf takedown | 333-221266 | 0001047469-18-003626 |
| 2018-02-16 | 424B5Shelf takedown | 333-221266 | 0001047469-18-000837 |
| 2018-02-14 | 424B5Shelf takedown | 333-221266 | 0001047469-18-000793 |
| 2017-11-14 | EFFECTDeclared effective | 333-221266 | 9999999995-17-002974 |
| 2017-11-01 | S-3Shelf registered | 333-221266 | 0001047469-17-006696 |
| 2016-10-26 | 424B4Final prospectus | 333-213917 | 0001047469-16-016293 |
| 2016-10-25 | EFFECTDeclared effective | 333-213917 | 9999999995-16-006067 |
| 2016-10-17 | S-1/AAmendment | 333-213917 | 0001047469-16-016127 |
| 2016-10-13 | S-1/AAmendment | 333-213917 | 0001047469-16-016087 |
| 2016-09-30 | S-1Registration filed | 333-213917 | 0001047469-16-015866 |
| 2016-08-17 | DRSDraft made public | 377-01373 | 0000912057-16-000652 |